A63.0 Anogenital (venereal) warts

Name of the Condition

• Anogenital (Venereal) Warts (ICD-10 Code A63.0)

Summary

Anogenital warts are benign growths caused by certain types of human papillomavirus (HPV) and primarily affect the genital or anal regions. These warts are transmitted through sexual contact and may present as single or multiple lesions. While often asymptomatic, they can cause discomfort or cosmetic concerns, and their presence may indicate exposure to HPV, a virus associated with other health risks.

Causes

Anogenital warts are caused by infection with low-risk types of human papillomavirus (HPV), most commonly types 6 and 11. Transmission occurs primarily through direct skin-to-skin contact during sexual activity, including vaginal, anal, or oral intercourse. The virus can also spread through close non-sexual contact in rare cases.

Risk Factors

• Engaging in unprotected sexual activity.
• Having multiple sexual partners.
• A history of other sexually transmitted infections (STIs).
• Immunosuppression or conditions that weaken the immune system.
• Early age at first sexual intercourse.

Symptoms

Symptoms may include visible growths in the genital or anal area, which can be raised, flat, or cauliflower-shaped. Some individuals experience itching, discomfort, or bleeding, particularly during intercourse or bowel movements. Many cases are asymptomatic, with warts detected only during routine examination.

Diagnosis

Diagnosis is typically based on visual inspection of the affected area. Healthcare providers may use magnification or apply acetic acid to enhance visibility of subtle lesions. For atypical cases, biopsy or HPV testing may be performed to confirm the diagnosis and rule out other conditions.

Treatment Options

Treatment aims to remove visible warts and may include topical medications (e.g., imiquimod, podophyllotoxin), cryotherapy, electrocautery, or surgical excision. Recurrence is common, and follow-up is recommended to monitor for new lesions or complications.

Prognosis and Follow-Up

With appropriate treatment, anogenital warts often resolve, but recurrence is possible due to the persistence of HPV. Regular follow-up is advised to assess for new growths or associated risks, such as HPV-related cancers, particularly in immunocompromised individuals.

Complications

Complications may include psychological distress, pain, or bleeding from lesions. Rarely, large or extensive warts can obstruct urination or defecation. There is also a potential link to certain HPV-related cancers, though this risk is higher with high-risk HPV types.

Lifestyle & Prevention

• Consistent and correct condom use can reduce transmission risk but does not eliminate it entirely.
• HPV vaccination is recommended for prevention of HPV-related conditions, including anogenital warts.
• Regular sexual health screenings and open communication with partners about STI status are important.

When to Seek Professional Help

Seek medical attention if you notice new growths in the genital or anal area, experience pain or bleeding, or have concerns about STI exposure. Prompt evaluation is also advised if warts recur after treatment or if you have a weakened immune system.

Tips for Medical Coders

Document the location (genital, anal, or both) and any associated symptoms or complications. Ensure the diagnosis is clearly linked to HPV infection, as this supports accurate coding. Note whether treatment was provided and any follow-up care, as these details may impact coding specificity.